Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. [electronic resource]
Producer: 20180717Description: 1016-1026 p. digitalISSN:- 1522-726X
- Aged, 80 and over
- Antithrombins -- administration & dosage
- Aortic Valve -- diagnostic imaging
- Aortic Valve Stenosis -- complications
- Cause of Death -- trends
- Dose-Response Relationship, Drug
- Europe -- epidemiology
- Female
- Fibrinolytic Agents -- administration & dosage
- Follow-Up Studies
- Heart Valve Prosthesis
- Heparin -- administration & dosage
- Hirudins -- administration & dosage
- Humans
- Incidence
- Infusions, Intravenous
- Male
- Peptide Fragments -- administration & dosage
- Practice Guidelines as Topic
- Prosthesis Design
- Recombinant Proteins -- administration & dosage
- Retrospective Studies
- Survival Rate -- trends
- Thrombolytic Therapy -- methods
- Thrombosis -- epidemiology
- Time Factors
- Transcatheter Aortic Valve Replacement -- standards
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.